Astrana Health logo

Astrana Health

ASTH | NASDAQ
Chart Builder DCF Calculator
$32.87
+$1.07 (+3.36%)
At close: Nov 16, 2026, 4:00 PM ET
$32.23
-$0.64 (-1.95%)
After-hours: Nov 16, 2026, 7:30 PM ET
+3.36%

Rating

Updated: Nov 16, 2026
53.2
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #216/1021 (Top 21%)

Key Statistics

Market Data

Market Cap $1.63B
1D Range
31.72 33.08
52W Range
18.16 49.81

Valuation (TTM)

PE 30.72
PB 1.90
EV/EBITDA 10.32

Valuation (NTM)

Forward PE 25.65
Forward PEG 0.19
Price Target $54.00
Loading financial charts...

Profile

Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical...

Sector Healthcare
Employees 3,000
IPO Date Mar 11, 2009
Fiscal Year January - December

Latest News

Astrana Health, Inc. (ASTH) Q3 2026 Earnings Call Transcript

10 days ago · seekingalpha.com

Astrana Health, Inc. (ASTH) Q3 2026 Earnings Call Transcript
Astrana Health Q3 Earnings Call Highlights

11 days ago · marketbeat.com

Astrana Health Q3 Earnings Call Highlights
Astrana Health, Inc. (ASTH) Q3 Earnings Lag Estimates

11 days ago · zacks.com

Astrana Health, Inc. (ASTH) Q3 Earnings Lag Estimates
Astrana Health, Inc. Reports Third Quarter 2026 Results

11 days ago · prnewswire.com

Astrana Health, Inc. Reports Third Quarter 2026 Results
Diamond Hill Small Cap Fund Q3 2026 Portfolio Activity

20 days ago · seekingalpha.com

Diamond Hill Small Cap Fund Q3 2026 Portfolio Activity
Is It Too Late to Buy Astrana Health Inc (ASTH) After 4.7% Rally? GF Value Says Undervalued

1 month ago · gurufocus.com

Is It Too Late to Buy Astrana Health Inc (ASTH) After 4.7% Rally? GF Value Says Undervalued
Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call

1 month ago · prnewswire.com

Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call
Why Astrana Health, Inc. (ASTH) is Poised to Beat Earnings Estimates Again

1 month ago · zacks.com

Why Astrana Health, Inc. (ASTH) is Poised to Beat Earnings Estimates Again
PRIVACY ALERT: AWKO Law Investigating Astrana Health Data Breach

2 months ago · businesswire.com

PRIVACY ALERT: AWKO Law Investigating Astrana Health Data Breach

2 months ago · globenewswire.com

Lowey Dannenberg, P.C. is Investigating Astrana Health, Inc. (NASDAQ: ASTH) for Potential Violations of the Federal Securities Laws

Earnings

Latest Earnings
Nov 5, 2026
EPS
$0.71
Beat +55.23%
REV
$1.02B
Beat +0.35%
Next Earnings
Mar 1, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
8
Consensus
Buy
Price Target
$54.00
Upside
+64.28%
Buy (8)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.